Monday - September 15, 2025
Goodwin Represented Harbour BioMed in Global Strategic Collaboration for up to $670 Million with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers
August 06, 2025
BOSTON, Massachusetts, Aug. 6 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

Goodwin Represented Harbour BioMed in Global Strategic Collaboration for up to $670 Million with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers

*

The Life Sciences team represented Harbour BioMed in a global strategic collaboration with Otsuka Pharmaceutical Co., Ltd. to advance BCMAxCD3 bispecific T-cell engagers for t . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products